Prevalence and Macrolide Resistance Phenotypes and Genotypes among Clinical Isolates of Streptococcus pneumoniae Collected in Sofia, Bulgaria from 2001 to 2005

References

• Appelbaum PC. Resistance among Streptococcus pneu-moniae: implications for drug selection. Clin Infect Dis 2002; 34: 1613–1620.
   PubMed Web of Science ®Google Scholar
• Nagai K, Appelbaum PC, Davies TA et al. Susceptibilities to telithromycin and six other agents and prevalence of macrolide resistance due to L4 ribosomal pro-tein mutation among 992 pneumococci from 10 Central and Eastern European countries. Antimicrob Agents Chemother 2002; 46 (2): 371-377.
   Google Scholar
• Leclercq R, Courvalin P. Resistance to macrolides and related antibiotics in Streptococcus pneumoniae. Antimicrob Agents Chemother 2002; 46: 2727–2734.
   PubMed Web of Science ®Google Scholar
• Montanari MP, Mingoia M, Giovanetti E, Varaldo PE. Differentiation of resistance phenotypes among erythromycin-resistant pneumococci. J Clin Microbiol 2001; 39: 1311–1315.
   PubMed Web of Science ®Google Scholar
• Tait-Kamradt A, Clancy J, Cronan M et al. MefE is nec-essary for the erythromycin-resistant M phenotype in S. pneu-moniae. Antimicrob Agents Chemother 1997; 41: 2251–2255.
   PubMed Web of Science ®Google Scholar
• Tait-Kamradt A, Davies T, Cronan M. et al. Mutation in 23S rRNA and ribosomal proten L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage.Antimicrob Agents Chemother 2000; 44: 2118-2125.
   Google Scholar
• Tait-Kamradt A, Davies T., Appelbaum PC et al. Two new mechanisms of macrolide resistance in clinical strains of S. pneumoniae from Eastern Europe and North America. Antimicrob Agents Chemother 2000; 44: 3395–3401.
   Google Scholar
• Reinert RR, Ringelstein A, van der Linden M, et al. Molecular epidemiology of macrolide-resistant Streptococcus pneumoniae isolates in Europe. J Clin Microbiol 2005; 43: 1294–1300.
   PubMed Web of Science ®Google Scholar
• Van Eldere J, Meekers E, Lagrou K et al. Macrolide-resistance mechanisms in Streptococcus pneumoniae isolates from Belgium. Clin Microbiol Infect 2005; 11: 332–334.
   Google Scholar
• Neeleman C, De Valk JA, Klaassen CHW et al. In-vitro susceptibility and molecular characterization of macrolide resis-tance mechanisms among Streptococcus pneumoniae isolates in the Netherlands: the duel 2 study. Clin Microbiol Infect 2005; 11: 312–318.
   Google Scholar
• Fotopoulou N, Tassios PT, Beste DV, et al. A common clone of erythromycin-resistant Streptococcus pneumoniae in Greece and the UK. Clin Microbiol Infect 2003; 9: 924–929.
   PubMed Web of Science ®Google Scholar
• Rantala M, Huikko S, Huovinen P, Jalava J. Prevalence and molecular genetics of macrolide resistance among Streptococcus pneumoniae isolates collected in Finland in 2002. Antimicrob Agents Chemother 2005; 49: 4180–4186.
   PubMed Web of Science ®Google Scholar
• Farrell DJ and Jenkins SG. Distribution across the USA of macrolide resistance and macrolide resistance mechanisms among Streptococcus pneumoniae isolates collected from patients with respiratory tract infections: PROTEKT US 2001-2002. J Antimicrob Chemother 2004; 54 (Suppl 51); i17-i22.
   Google Scholar
• Reinert RR, Wild A, Appelbaum P et al. Ribosomal mutations conferring resistance to macrolides in Streptococcus pneumoniae clinical strains isolated in Germany. Antimicrob Agents Chemother 2003; 47: 2319–2322.
   Google Scholar
• Davies TA, Kelly LM, Jacobs MR, Appelbaum PC. Antipneumococcal activity of telithromycin by agar dilution, microdilution, E-test and disk diffusion. J Clin Microbiol 2000; 38: 1444–1448.
   PubMed Web of Science ®Google Scholar
• Setchanova L. Clinical Isolates and Nasopharyngeal Carriage of Antibiotic-Resistant Streptococcus pneumoniae in Hospital for Infectious Diseases, Sofia, Bulgaria, 1991-1993. Microb Drug Resist 1995; 1: 79–84.
   PubMed Web of Science ®Google Scholar
• Fasola EL, Bajaksouzian S, Appelbaum PC and Jacobs MR. Variation in erythromycin and clindamycin susceptibilities of Streptococcus pneumoniae by four test methods. Antimicrob Agents Chemother 1997; 41: 129–134.
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing: 15th informational supplement. CLSI/NCCLS document M100-515. Clinical and Laboratory Standards Institute, Wayne, Pa.
   Google Scholar
• Sutcliffe J, Tait-Kamradt A, Wondrack L. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob Agents Chemother 1996; 40: 1817–1824.
   PubMed Web of Science ®Google Scholar
• Sutcliffe J, Grebe T, Tait-Kamradt A et al. Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother 1996; 40: 2562–2566.
   PubMed Web of Science ®Google Scholar
• Sorensen UBS. Typing of pneumococci by using 12 pooled antisera. J Clin Microbiol 1993; 31: 2097-2100.
   Google Scholar
• Reinert RR, Reinert S, Van der Linden M, et al. Antimicrobial susceptibility of Streptococcus pneumoniae in eight European countries from 2001 to 2003. Antimicrob Agents Chemother 2005; 49: 2903–2913.
   PubMed Web of Science ®Google Scholar
• Felmingham D, Reinert RR, Hirakata Y, Rodloff A. Increasing prevalence of antimicrobial resistance among iso-lates of Streptococcus pneumoniae from the PROTEKT sur-veillance study, and comparative in vitro activity of the ketolide, telithromycin. J Antimicrob Chemother 2002; 50 (Suppl.S1): 25-37.
   Google Scholar
• Marchese A, Gualco L, Cochetti I, et al. Antibiotic sus-ceptibility and serotype distribution in Streptococcus pneumo-niae circulating in Italy: results of the SEMPRE surveillance study (2000-2002). Int J Antimicrob Agents 2005; 26: 138–145.
   PubMed Web of Science ®Google Scholar
• Klugman KP, Lonks JR. Hidden epidemic of macrolide- resistant pneumococci. Emerg Infect Dis 2005; 11: 802–807.
   PubMed Web of Science ®Google Scholar
• Lonks JR. What is the clinical impact of macrolide resistance? Curr Infect Dis Rep 2004; 6: 7–12.
   PubMedGoogle Scholar
• Farrell DJ, Morrissey I, Bakker S, Felmingham D. Molecular characterization of macrolide resistance mechanisms among Streptococcus pneumoniae and Streptococcus pyo-genes isolates from PROTEKT 1999-2000 study. J Antimicrob Chemother 2002; 50 (Suppl. Si): 39-47.
   Google Scholar